The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the pre-clinical implementation of advanced human heart models. SAN DIEGO, CA – February 14, 2023 –...
Read MoreRedesigned AnaBios Website Focuses on Human Tissue, Cells & Functional Assays
SAN DIEGO, CA – January 30, 2023 – AnaBios is pleased to announce the redesign of their website describing their human tissue platform offerings, including off-the-shelf and custom tissue samples from their industry-leading biorepository, as well...
Read MoreNew 3D Images of Human DRG Samples From Alpenglow Biosciences
Alpenglow Biosciences recently created new 3D images of human DRG samples from AnaBios using their unique version of light sheet microscopy. Staining: computation H&E (nuclei: ToPro3, protein: Eosin) Microscope Meta-Data Zoom image: 638 nm Excitation –...
Read MoreAnaBios Announces Inaugural Translational Research Conference
SAN DIEGO, CA – November 8, 2022 – AnaBios today announced the inaugural Translational Research Conference to be held February 27-28, 2023 in San Diego, California. The conference will gather pharmaceutical, biotech and academic scientists from...
Read MoreVP of R&D Named Associate Editor of Frontiers in Physiology
Najah Abi-Gerges, Ph.D., Vice President of Research & Development at AnaBios, was recently named a new Associate Editor of the Cardiac Electrophysiology section of Frontiers in Physiology, the second most-cited journal in its field with more...
Read More